openPR Logo
Press release

Jerry Calumn has been selected as Event Manager for Lone Star Ride Fighting AIDS

02-14-2011 12:23 PM CET | Associations & Organizations

Press release from: Lone Star Ride Fighting AIDS

After an extensive search and interview process, Jerry Calumn accepted the position of event manager for Lone Star Ride Fighting AIDS and will be leading the agency into its second decade. He will be returning to Dallas HIV/AIDS event fundraising after a successful career in marketing and communications in Los Angeles and New York.

"I am excited to work in an organization with such a strong legacy and an even stronger foundation of committed riders and volunteers," he said of his selection. "Living with this disease myself for 17 years, I'm glad we have organizations like Lone Star Ride Fighting AIDS raising funds, creating hope, and focusing on moving forward."

Jerry has been a fierce advocate for the HIV/AIDS community having served a number of agencies including Resource Center Dallas from 1990-1998, and helping to create the American Academy of HIV Medicine. Lone Star Ride Fighting AIDS will also benefit from Jerry's work experience in the for-profit community most recently as a communications and product Consultant at his firm Calumn Communications in the New York area.

"I have no doubt that Jerry's energy and talent will be a great addition to our LSRFA family. We are very excited to have someone of his caliber as our event manager," said Laura Kerr, President of the LSRFA Board of Directors, in announcing the choice.

Search committee chair Robert Moore called Jerry "an excellent fit for this role." Adding, "He has passion, commitment, and is a rider himself. He lives openly as an HIV+ man. He knows the issues the HIV/AIDS community and the HIV service providers face every day."

Jerry Calumn will be taking the helm of Lone Star Ride Fighting AIDS (LSRFA), an agency that exists to raise funds for North Texans living with HIV/AIDS while at the same time raising awareness of this disease. Founded in 2001, LSRFA is a grassroots, volunteer driven 501 (c) 3 non-profit organization that produces a number of fundraising and awareness raising events throughout the year.

Commemorating its 11th Anniversary in 2011, Lone Star Ride Fighting AIDS ends the year with the signature event; a two-day cycling adventure through scenic suburban and country roads winding through and around Dallas/Fort Worth on September 24 and 25, 2011. The ride offers a number of routes ranging from a 1 Day - 45 mile ride to a 2 Day - 180 mile ride. For both riders and crew members, it's a great way to meet new friends and have a lot of fun while supporting a serious cause. As a result of strong community support, LSRFA has donated nearly $2 million to our three beneficiary agencies.

2011 marks the thirtieth anniversary of the first cases of what is now known as HIV/AIDS in the United States. The HIV/AIDS community has made great strides in those thirty years however there is still more to be done. Texas ranks fourth nationally with the highest number of HIV/AIDS cases, and Dallas currently has the highest rate of infection in Texas.

Health officials estimate that one in 22 African-Americans will be diagnosed with HIV in their lifetime, and currently HIV/AIDS is one of the leading causes of death in women worldwide. In some age categories, HIV/AIDS is the leading cause of death in women worldwide.

From exiting event manager David Minehart, "I have been privileged to serve as Lone Star Ride Fighting AIDS event manager since 2007 and steering committee volunteer since 2001. I am pleased the search committee has acted quickly in identifying the next event manager to lead this extraordinary event into its second decade. Best wishes to Mr. Calumn and to Lone Star Ride Fighting AIDS 2011. See you-all September 24 and 25!"

Commemorating its 11th Anniversary in 2011, Lone Star Ride Fighting AIDS is a two-day cycling adventure through scenic suburban and country roads winding through and around Dallas/Fort Worth on September 24 and 25, 2011. The ride offers a number of routes ranging from a 1 Day - 45 mile ride to a 2 Day - 180 mile ride. An independent, non-profit organization, the LSRFA benefits AIDS Services of Dallas (ASD), AIDS Outreach Center of Tarrant County (AOC) and Resource Center Dallas (RCD). Monies raised by the ride are used by the beneficiaries to offer services including housing, hot meals, food pantries, HIV testing, counseling and other basic needs for more than 20,000 clients with HIV/AIDS in North Texas. As a result of strong community support, LSRFA has donated nearly $2 million to our three beneficiary agencies since 2001.

Keith Hobbs
Lone Star Ride Fighting AIDS
2701 Reagan Street
Dallas, TX 75219

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Jerry Calumn has been selected as Event Manager for Lone Star Ride Fighting AIDS here

News-ID: 162297 • Views:

More Releases for HIV

HIV Drugs Market - Defeating HIV Together: Advancing Treatment Options for a Bri …
Newark, New Castle, USA: The "HIV Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors HIV Drugs Market: https://www.growthplusreports.com/report/hiv-drugs-market/7792 This latest report researches the industry structure, sales, revenue,
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways